Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients
Open Access
- 28 June 2012
- journal article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 125 (9), 937.e17-937.e24
- https://doi.org/10.1016/j.amjmed.2011.12.016
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary AngioedemaNew England Journal of Medicine, 2010
- Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiencyJournal of Allergy and Clinical Immunology, 2009
- Hereditary AngioedemaNew England Journal of Medicine, 2008
- Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: Functional and structural correlatesMolecular Immunology, 2008
- Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyondJournal of Allergy and Clinical Immunology, 2004
- Bradykinin-Mediated AngioedemaNew England Journal of Medicine, 2002
- Increased vascular permeability in C1 inhibitor–deficient mice mediated by the bradykinin type 2 receptorJCI Insight, 2002
- Hereditary AngioedemaArchives of Internal Medicine, 2001
- Hereditary and Acquired C1-Inhibitor DeficiencyMedicine, 1992
- Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edemaJCI Insight, 1971